Caffeine consumption outcomes on amyotrophic lateral sclerosis disease progression and cognition.

Huin, Vincent; Blum, David; Delforge, Violette; Cailliau, Emeline; Djeziri, Sofia; Dujardin, Kathy; Genet, Alexandre; Viard, Romain; Attarian, Shahram; Bruneteau, Gaelle; Cassereau, Julien; Genestet, Steeve; Kaminsky, Anne-Laure; Soriani, Marie-Hélène; Lefilliatre, Mathilde; Couratier, Philippe; Pittion-Vouyovitch, Sophie; Esselin, Florence; De La Cruz, Elisa; Guy, Nathalie; Kolev, Ivan; Corcia, Philippe; Cintas, Pascal; Desnuelle, Claude; Buée, Luc; Danel-Brunaud, Véronique; Devos, David; Rolland, Anne-Sophie

doi:10.1016/j.nbd.2024.106603

Public

Caffeine consumption outcomes on amyotrophic lateral sclerosis disease progression and cognition.

Shared by NobleBlocks on Sep 1, 2024 • 12:00 AM UTC

Authors:

Vincent Huin

David Blum

Violette Delforge

Abstract

Caffeine consumption outcomes on Amyotrophic Lateral Sclerosis (ALS) including progression, survival and cognition remain poorly defined and may depend on its metabolization influenced by genetic variants. 378 ALS patients with a precise evaluation of their regular caffeine consumption were monitore...

Subject

Amyotrophic lateral sclerosis

Caffeine

Cognition

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!